AMP
Lung Cancer Groups Seek Public Comment on Updated Biomarker Testing Guidelines
Updated guidelines recommend certain biomarker tests for early- and late-stage lung cancer at the time of diagnosis.
AMP Sues FDA Over Laboratory-Developed Test Final Rule
Filed in the US District Court for the Southern District of Texas, the lawsuit is the second legal challenge to the rule following a suit filed by ACLA in June.
Researchers described the process they took to adapt their methodology for improved BRCA variant classification through ClinGen in a new study this week.
AMP Publishes Recommendations for DPYD Genotyping Assays
The report is intended to ensure that the appropriate variants are included in clinical pharmacogenomic DPYD assays.
Association for Molecular Pathology Releases New Tumor Mutational Burden Testing Recommendations
The joint consensus guideline, authored by AMP, ASCO, CAP, and SITC, seeks to establish evidence-based standards for validation and reporting of TMB tests in the clinic.
Nov 7, 2022
Aug 8, 2022